Upcoming Meetings in the Series:

ADC Payload Summit
May 2024
London, UK
3rd World ADC

June 2024
Incheon, South Korea
 2nd ADC Toxicity

 July 2024

The ADC Wave Continues Throughout 2023

Thank you to our speakers, sponsors, and delegates who joined us in San Diego for the summit! If you are interested in the 2024 event, please get in touch at adc@hansonwade.com

Accelerate Your Antibody-Drug Conjugate Pipeline to
Become a Front-Line Treatment

The ADC momentum has continued to dominate the oncology field throughout 2023, with the long-awaited approval of ImmunoGen’s ELAHERE – the 9th ADC to be approved in just three years. To add to the excitement, this incredible breakthrough is the first ADC for platinum-resistant ovarian cancer, proving their potential for treatments beyond breast cancer.

Whether you have just ventured into the ADC space or are an ADC guru, the 14th World ADC San Diego had you covered. It accompanied attendees from early discovery to late-stage manufacturing and regulatory challenges, this meeting was designed with one aim in mind: to maximize the therapeutic window of your ADC, and propel ADCs to become life-changing, front-line treatments for oncology patients.

Relive the 2022 Event Highlights

With over 800 world-leading ADC experts in attendance including Daiichi Sankyo, ImmunoGen, AbbVie, Gilead Sciences, and Seagen, this is set to be the biggest-ever convergence of the ADC community yet and you cannot afford to miss it!

1000+ Attendees Including...

End-To-End ADC Development Content for All Members of Your Team

Whether you have just ventured into the ADC space or are an ADC guru, we’ve got you covered.

The 120 + World Class Speakers Included

Esohe Idusogie

Head of Process Quality & CMC Analytical

ADC Therapeutics

Gail Lewis

Senior Principal Scientist


Jun Hasewga


Daiichi Sankyo

Lara McGrath

Director Translational Medicine


Meijuan Li

Vice President & Head of Biostatistics & Translational Science & Oncology


Nathan Ihle

Senior Vice President

Bolt Biotherapeutics

Patrick Zweidler-McKay

Executive Medical Director


Ziping Wei

Chief Executive Officer

Bliss Bio

Proud To Partner With

Lead Partner

Senior Partners:



About World ADC Series

The World ADC team ploughs its collective energy in to sourcing the insights you need. We investigate the most challenging problems facing the industry; source the leading experts who have game-changing solutions; and distil this into accessible formats of information exchange – for you. From globally leading conferences to webinars and industry reports, whatever the information you need, World ADC can offer you the insights you need to accelerate your ADC programs.

The value World ADC provides you is the power of insight and connections. Not artificial, and not short-lived. We nurture the right environments in which people can communicate problems and solutions; share novel data and forge networks across the industry that will make each of your endeavours more informed and more robust.

We share a common belief with the industry – that the potential of antibody drug conjugates is enormous. In the war against cancer, ADCs can be a game-changer and we know that the right insights and connections can sharpen the weapons that are in your arsenal.

Join us at the heart of the ADC community to improve your programmes and be part of the mission to develop better antibody drug conjugate drugs.